These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8871612

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41.
    Peterson M, Miller J.
    Nature; 1992 Jun 18; 357(6379):596-8. PubMed ID: 1608470
    [Abstract] [Full Text] [Related]

  • 3. The p41 isoform of invariant chain is a chaperone for cathepsin L.
    Lennon-Duménil AM, Roberts RA, Valentijn K, Driessen C, Overkleeft HS, Erickson A, Peters PJ, Bikoff E, Ploegh HL, Wolf Bryant P.
    EMBO J; 2001 Aug 01; 20(15):4055-64. PubMed ID: 11483509
    [Abstract] [Full Text] [Related]

  • 4. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
    Bevec T, Stoka V, Pungercic G, Dolenc I, Turk V.
    J Exp Med; 1996 Apr 01; 183(4):1331-8. PubMed ID: 8666891
    [Abstract] [Full Text] [Related]

  • 5. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA, Chaturvedi P, Lee-Chan EC, Rider BJ, Singh B.
    J Immunol; 1996 Jun 01; 156(11):4232-9. PubMed ID: 8666792
    [Abstract] [Full Text] [Related]

  • 6. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.
    Stebbins CC, Peterson ME, Suh WM, Sant AJ.
    J Immunol; 1996 Dec 01; 157(11):4892-8. PubMed ID: 8943393
    [Abstract] [Full Text] [Related]

  • 7. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
    Reich M, Zou F, Sieńczyk M, Oleksyszyn J, Boehm BO, Burster T.
    Cell Immunol; 2011 Dec 01; 269(2):96-103. PubMed ID: 21543057
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation.
    Bertolino P, Staschewski M, Trescol-Biémont MC, Freisewinkel IM, Schenck K, Chrétien I, Forquet F, Gerlier D, Rabourdin-Combe C, Koch N.
    J Immunol; 1995 Jun 01; 154(11):5620-9. PubMed ID: 7751615
    [Abstract] [Full Text] [Related]

  • 14. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC, Steele CR, Gu L, Song W, Pierce SK.
    J Immunol; 1999 Jun 15; 162(12):7171-80. PubMed ID: 10358163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
    Gautam AM, Yang M, Milburn PJ, Baker R, Bhatnagar A, McCluskey J, Boston T.
    J Immunol; 1997 Sep 15; 159(6):2782-8. PubMed ID: 9300699
    [Abstract] [Full Text] [Related]

  • 18. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R, Hang HC, Mintern JD, Kim YM, Cuvillier A, Nishimura M, Yamada K, Shirahama-Noda K, Hara-Nishimura I, Ploegh HL.
    J Immunol; 2005 Jun 01; 174(11):7066-74. PubMed ID: 15905550
    [Abstract] [Full Text] [Related]

  • 19. Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.
    Fineschi B, Arneson LS, Naujokas MF, Miller J.
    Proc Natl Acad Sci U S A; 1995 Oct 24; 92(22):10257-61. PubMed ID: 7479763
    [Abstract] [Full Text] [Related]

  • 20. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
    Guncar G, Pungercic G, Klemencic I, Turk V, Turk D.
    EMBO J; 1999 Feb 15; 18(4):793-803. PubMed ID: 10022822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.